United states 3 items

Trials, agents, guidance

• Guideline 2026 ACC/AHA multisociety guideline on the management of dyslipidemiaCurrent US guideline (replaces 2018)
• Guideline NLA focused update on the use of Lp(a) in clinical practice (2024)Current US lipidology statement
• Guideline AHA scientific statement: Lp(a) as a genetically determined, causal and prevalent risk factor (2022)Current